No Data
No Data
ZhuZhou QianJin Pharmaceutical Unit Gets China Nod for Premature Ejaculation Tablets; Shares Fall 3%
Is ZhuZhou QianJin PharmaceuticalLtd (SHSE:600479) A Risky Investment?
Why You Might Be Interested In ZhuZhou QianJin Pharmaceutical Co.,Ltd (SHSE:600479) For Its Upcoming Dividend
Qianjin Pharma Unit Gets Nod for Supplemental New Drug Application for Teralithe Biosimilar
ZhuZhou QianJin Pharmaceutical Co.,Ltd's (SHSE:600479) Market Cap Dropped CN¥378m Last Week; Individual Investors Bore the Brunt
ZhuZhou QianJin Pharma Gets Nod to Register Blood Circulation Drug in Canada
No Data